Concepedia

Stephen H. Docter

SH

Statistics

Publications

5

Citations

150

H-Index

5

Active since

1994

Affiliations

Skin Research Center(Current)

Stephen H. Docter is an author at Skin Research Center specializing in pharmacology, medicinal chemistry, and pharmacy.

Publications per year

1994–2004

5

Publications

5

Structure−Activity Relationship Studies on 1-[2-(4-Phenylphenoxy)ethyl]pyrrolidine (SC-22716), a Potent Inhibitor of Leukotriene A<sub>4</sub> (LTA<sub>4</sub>) Hydrolase

Thomas D. Penning, Nizal S. Chandrakumar, Barbara B. Chen et al. · Journal of Medicinal Chemistry · 2000 · 68 citations · Full text

, , +15

Antiinflammatory effects of second-generation leukotriene B4 receptor antagonist, SC-53228: Impact upon Leukotriene B4- and 12(R)-HETE- mediated events

D. J. Fretland, C. P. Anglin, Meire Bremer et al. · Inflammation · 1995 · 22 citations

, , +15

ChemInform Abstract: Synthesis and Biological Evaluation of the 1,5‐Diarylpyrazole Class of Cyclooxygenase‐2 Inhibitors: Identification of 4‐(5‐(4‐Methylphenyl)‐3‐ (trifluoromethyl)‐1H‐pyrazol‐1‐yl)benzenesulfonamide (SC‐58635, Celecoxib).

Thomas D. Penning, J. J. TALLAY, Stephen R. Bertenshaw et al. · ChemInform · 1997 · 21 citations

, , +14

Synthesis of cinnamic acids and related isosteres as potent and selective αvβ3 receptor antagonists

Thomas D. Penning, Mark A. Russell, Barbara B. Chen et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 20 citations · Full text

, , +9

Synthesis and pharmacological activity of SC-53228, a leukotriene B4 receptor antagonist with high intrinsic potency and selectivity

Stevan W. Djurić, Stephen H. Docter, Stella S. Yu et al. · Bioorganic & Medicinal Chemistry Letters · 1994 · 19 citations

, , +10

1–5 of 5